— Intracavitary chemo or immunotherapy for upper urinary tract transitional cell carcinomas has been recently introduced. From published data, Bacillus Calmette-Guerin appears to give significant and durable response rates (70% as prophylaxis, 81% as therapy) with acceptable side effects. The anecdotal use of chemotherapeutical agents prevents any conclusion being made about the therapeutical impact. To date, intracavitary percutaneous Bacillus Calmette-Guerin treatment is suggested for patients with “in situ” or occult carcinoma of the upper urinary tract, bilateral and synchronous tumors and/or with severe renal failure or not suitable for radical surgery.
SeamanE.K., SlawnK.M., BensonM.C.: Treatment options for upper tract transitional cell carcinoma. Urol. Clin. N. Am., 20 (2): 349, 1993.
2.
TascaA., ZattoniF., BassiP., GarbeglioA., VilliG., MeneghiniA.: Endourologic treatment of transitional cell carcinoma of the upper urinary tract. World J. Endourol., 6: 253, 1992.
3.
PaganoF., BassiP. (Eds): BCG immunotherapy of bladder cancer. CLEUP, Padova1994.
4.
HerrH.W.: Durable response of a carcinoma in situ of the renal pelvis to topical Bacillus Calmette-Guerin. J. Urol., 135: 531, 1985.
5.
SmithA.D., OrihuelaE., CrowleyA.R.: Percutaneous management of renal pelvic tumors: a treatment option in selected cases. J. Urol., 137: 852, 1987.
6.
StuderU.E., CasanovaG., KraftR., ZinggE.: Percutaneous Bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ. J. Urol., 142: 975, 1989.
7.
RamseyJ.C., SolowayM.S.: Instillation of Bacillus Calmette-Guerin into the renal pelvis of a solitary kidney for the treatment of transitional cell carcinoma. J. Urol., 143: 1220, 1990.
8.
SchoenbergM.P., van ArsdalenK.N., WeinA.J.: The management of transitional cell carcinoma in solitary renal units. J. Urol., 146: 700, 1991.
9.
SharpeJ.R., DuffyG., ChinJ.L.: Intrarenal Bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ. J. Urol., 149: 457, 1993.
10.
BassiP., TascaA., ZattoniF., CalabròA., AbatangeloG., MilaniC., MeneghiniA., PaganoF.: Tollerabilità di un trattamento topico percutaneo con Bacillo di Calmette-Guerin delle neoplasie transizionali superficiali delle alte vie urinarie. Urologia, 60 (1): 34, 1993.
11.
BassiP., TascaA., ZattoniF., AbatangeloG., LevoratoC.A., PaganoF.: Trattamento topico percutaneo con Bacillo di Calmette-Guerin delle neoplasie superficiale delle alte vie urinarie: indicazioni, modalità e tollerabilità. Atti 3° Cong. Naz. SIURO, Milano, 119, 1993.
12.
BellmanG.C., SweetserP., SmithA.D.: Complications of intracavitary Bacillus Calmette-Guerin after percutaneous resection of upper tract transitional cell carcinoma. J Urol., 151: 13, 1994.
13.
LammD.L., van der MeijdenA.P.M., MoralesA., BrosmanS., CatalonaW.J., HerrH.W., SolowayM.S., StegA., DebruyneF.M.J.: Incidence and treatment of complications of Bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J. Urol., 147: 596, 1992.
14.
MukamelE., LayfieldL.J., HawkinsR.A., de KernionJ.B.: The effect of Bacillus Calmette-Guerin on the urinary system of pigs. J. Urol., 139: 165, 1988.
15.
MukamelE., VilkovskyE., HadarH., EngelsteinD., NussbaumB., ServadioC.: The effect of intravesical Bacillus Calmette-Guerin therapy on the upper urinary tract. J Urol., 146: 980, 1991.
GittesR.F.: Management of transitional cell carcinoma of the upper urinary tract: case for conservative local excision. Urol. Clin. N. Am., 7: 559, 1980.
18.
PowderJ.R., MosbergW.H., PierpontR.S., YoungJ.D.: Bilateral primary carcinoma of the ureter: topical intraureteral thiotepa. J. Urol., 132: 349, 1984.
19.
De KockM.L.S., BreytenbachI.H.: Local excision and topical thiotepa in the treatment of transitional cell carcinoma of the renal pelvis: a case report. J. Urol., 135: 566, 1985.
20.
SmithA.Y., VitaleP.J., LoweB.A.: Treatment of superficial papillary transitional cell carcinoma of the ureter by vesicoureteral reflux of mitomycin C.J. Urol., 138: 1231, 1987.
21.
EasthamJ.A., HuffmanJ.L.: Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors. J. Urol., 150: 324, 1993.
22.
van HelsdingerP.J.R.O., RikkenC.H.M.: Treatment of urothelial carcinoma of the upper urinary tract following Prostacystectomy with mitomycin C instillation in the ileal loop. J. Urol., 136: 461, 1986.
23.
BassiP., PaganoF.: Il BCG nel trattamento delle neoplasie superficiali della via escretrice. In: Early cancer in Urology. Editore: RoccaRossetti S.Archimedica, Torino, 99–107, 1995.
